From: Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis
Control group | Treatment group | |||
---|---|---|---|---|
log2 fold-change | p value1 | log2 fold-change | p value1 | |
Triacylglycerols | −0.1024 | 0.970 | 0.3003 | 0.999 |
Saturated Triacylglycerols | −0.5770 | 0.066 | −0.4644 | 0.184 |
Cholesteryl Esters | −0.5933 | 0.335 | −0.5774 | 0.150 |
Total Ceramides | 0.0968 | 0.315 | −0.1821 | 0.298 |
Ceramide NS | 0.5423 | 0.111 | 0.2131 | 0.944 |
Ceramide NdS | −0.4128 | 0.069 | −0.5668 | 0.091 |
Ceramide NP | 0.0599 | 0.769 | −0.1532 | 0.284 |
Ceramide NH | −0.2078 | 0.208 | −0.4917 | 0.123 |
Ceramide AS | 0.4944 | 0.996 | 0.2455 | 0.945 |
Ceramide AdS | −0.3060 | 0.384 | −0.1295 | 0.280 |
Ceramide AP | −0.0696 | 0.236 | 0.1053 | 0.596 |
Ceramide AH | 0.0762 | 0.434 | 0.1284 | 0.718 |
Ceramide EOS | 0.7337 | 0.332 | 0.4697 | 0.881 |
Ceramide EOH | 0.2010 | 0.985 | −0.0974 | 0.279 |
Ceramide N | 0.0846 | 0.829 | −0.2062 | 0.276 |
Ceramide A | 0.4749 | 0.252 | 0.2258 | 0.855 |
Ceramide EO | 0.5965 | 0.086 | 0.3288 | 0.852 |
Saturated fatty acids | 0.0781 | 0.926 | −0.1871 | 0.310 |
Monounsaturated fatty acids | 0.2740 | 0.823 | 0.8698 | 0.419 |
Polyunsaturated fatty acids | 1.6923 | 0.079 | 3.0714 | 0.039 |
Unsaturated fatty acids | 0.7573 | 0.290 | 1.7619 | 0.101 |
Total Non-esterified fatty acids | 0.1200 | 0.957 | −0.0565 | 0.475 |